Hapvida signs nine-year Roche deal to modernize diagnostics operations
Partnership includes about R$250 million in investment by Roche and R$1.5 billion in services and supplies to be contracted by Hapvida over nine years.
Partnership includes about R$250 million in investment by Roche and R$1.5 billion in services and supplies to be contracted by Hapvida over nine years.
Brazil’s health regulator is waiting for additional safety and efficacy data from Roche before deciding whether the treatment can return to the market.